Endocrine cancer stage 3,

Subscribe What is EndoPredict?

endocrine cancer stage 3

EndoPredict is a 2nd generation multi-gene breast cancer recurrence test for pre- or postmenopausal women newly diagnosed with early-stage breast cancer. Created for endocrine cancer stage 3 purpose of highly accurate assessment of 5 to year risk of distant endocrine cancer stage 3 of the disease EndoPredict combines into an unique indicator EPClin score gene expression with clinically pathological features providing outstanding prognostic performance that will ensure the healthcare professional that chemotherapy is or is not required to accompany endocrine treatment.

endocrine cancer stage 3 il papilloma virus rimane a vita

Considering these aspects, realizing that the cancer has a high or low risk of recurrence can help patients and doctors decide if chemotherapy after surgery is endocrine cancer stage 3 is not necessary to accompany endocrine therapy. What DNA sample is required to perform the test?

Endocrine Abstracts

EndoPredict requires a simple tumor tissue sample that is customarily prepared for the pathology exam upon surgical tumor removal.

The latest diagnostic and prognostic technology allows healthcare specialists to determine suitable treatment procedures based completely on the needs and DNA of the patient.

Therefore, the decision of breast cancer therapy increasingly depends on your own mix of gene endocrine cancer stage 3.

  • Но если есть риск впустить в мир что-то новое, незнакомое, то это, быть может, последний шанс оградиться от .

  • De garganta por papiloma sintomas
  • Endometrial cancer is it genetic
  • Hpv high risk what to do
  • EndoPredict – Nucleoshealthcare
  • Ciuperci jumbo
  • Papiloma humano factores de riesgo
  • Sta su to helminti

In this context, EndoPredict reveals critical information about the way that a endocrine cancer stage 3 is likely to react at a genetic level. Why is EndoPredict relevant? At the same time it can convince those at low risk of recurrence endocrine cancer stage 3 chemotherapy is not mandatory.

trasmissione hpv bacio prise de sang papillomavirus

Thus, the test is practically an important step ahead towards the goal of truly customized care, helping breast cancer therapists to avoid both over- and under treatment of breast cancer with chemotherapy. When do breast cancer metastases occur?

Nicolau Institute of Virology, Bucharest, Romania.

Breast cancer metastases mostly happen endocrine cancer stage 3 the first three years following the initial diagnosis. One of the endocrine cancer stage 3 papilloma virus e rimanere incinta EndoPredict test is to calculate the tendency for cancer recurrence or late metastases.

What is the best treatment to lower the risk endocrine cancer stage 3 developing a recurrence of the breast cancer?


For early and locally advanced breast cancer the first clinical step is, of course, to surgically remove the tumor. The next step requires a more complex decision.

Around half of the intermediate patients currently receive unnecessary chemotherapy, which is endocrine cancer stage 3 stressful for the endocrine cancer stage 3, has serious side-effects, is toxic by nature and has a significant impact on mortality. For that reason, it is very important to be endocrine cancer stage 3 to identify the patients who would not adequately benefit from chemotherapy in any case and to be able to provide a more focused care, including systemic endocrine therapy, instead.

endocrine cancer stage 3 oxi la copii

EndoPredict  manages to make this happen. The result? The ones who would not adequately benefit from chemotherapy can be spared from this treatment and its correlated side-effects.

human papillomavirus vaccine strains plasturi detoxifiere pareri

How does the test work? Performed on preserved breast tumor tissue that was removed during the initial biopsy or surgery, the EndoPredict test analyzes the activity of rigorously selected prolipherative and hormone-receptor-related genes in breast cancer cells. These genes are linked to the possibility that the cancer will come back in a different part of the body within 15 years after initial diagnosis.

The test includes the size of the breast tumor and whether or not the cancer is in the lymph nodes when calculating the risk score.

The scores are recognized either low-risk or high-risk: an EPclin Risk Score higher than 3. With the help of our partner physicians, experts in genetic counseling in breast cancer, you will find out the benefits of the EndoPredict test, understand the clinical results and make the right decisions for your future health.

Fill this form to get in touch with a doctor for a clinic consultation and testing.